Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-016264·PMV Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
PMV PHARMACEUTICALS INC
Common stock, par value $0.00001 per share · CUSIP: 69353Y103
Event date: 2025-09-30
- Filing-level shares
- 2,636,548.00
- Percent of class
- 4.98%
- Sio Capital Management, LLC
Shares: 2,636,548.00 · Class: 4.98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-016264
- Form type
- SCHEDULE 13G/A
- Filer
- PMV Pharmaceuticals, Inc.
- CIK
- CIK 1699382
- Filed
- Nov 12, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership